Prognostic significance of cyclin D1 protein expression and gene amplification in invasive breast carcinoma

Longer Survival in Patients with Breast Cancer with Cyclin D1 Over-Expression after Tumor Recurrence: Longer, but Occupied with Disease

(2014) Jaesik Chung et al.   Journal of Breast Cancer

European cancer mortality predictions for the year 2013

(2013) M. Malvezzi et al.   ANNALS OF ONCOLOGY

Cell cycle regulators cyclin D1 and CDK4/6 have estrogen receptor-dependent divergent functions in breast cancer migration and stem cell-like activity

(2013) Rebecca Lamb et al.   CELL CYCLE

Ki-67 expression is increased in p16-expressing triple-negative breast carcinoma and correlates with p16 only in p53-negative tumors

(2013) Jessica Sugianto et al.   HUMAN PATHOLOGY

Cyclin D1 in invasive breast carcinoma: favourable prognostic significance in unselected patients and within subgroups with an aggressive phenotype

(2012) Eleni Mylona et al.   HISTOPATHOLOGY

Characterisation of amplification patterns and target genes at chromosome 11q13 in CCND1-amplified sporadic and familial breast tumours

(2011) Karolina Holm et al.   BREAST CANCER RESEARCH AND TREATMENT

Detection of CHK1 and CCND1 gene copy number changes in breast cancer with dual-colour fluorescence in-situ hybridization

(2011) Kun Mu et al.   HISTOPATHOLOGY

American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer

(2010) M. Elizabeth H. Hammond et al.   JOURNAL OF CLINICAL ONCOLOGY

New Molecular Classifications of Breast Cancer

(2009) M. Cianfrocca et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Cyclin D1 expression is associated with poor prognostic features in estrogen receptor positive breast cancer

(2008) Kirsimari Aaltonen et al.   BREAST CANCER RESEARCH AND TREATMENT